Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio.

Tsai, Jeng-Shiuan; Wei, Sheng-Huan; Chen, Chian-Wei; Yang, Szu-Chun; Tseng, Yau-Lin; Su, Po-Lan; Lin, Chien-Chung; Su, Wu-Chou

Tsai, Jeng-Shiuan; Wei, Sheng-Huan; Chen, Chian-Wei; Yang, Szu-Chun; Tseng, Yau-Lin; Su, Po-Lan; Lin, Chien-Chung; Su, Wu-Chou.

Afiliação

Tsai JS; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Wei SH; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Chen CW; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Yang SC; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Tseng YL; Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Su PL; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Lin CC; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Su WC; Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

Pharmaceuticals (Basel) ; 15(11)2022 Nov 14.

Article em En | MEDLINE | ID: mdl-36422537

Palavras-chave

neutrophil-to-lymphocyte ratio; non-small cell lung cancer; pembrolizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google